Found 52 of ic50 data for polymerid = 8242 TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 34nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 42nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 46nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 62nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 68nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 78nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 99nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 140nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 140nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 156nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 158nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 187nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 187nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 204nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 207nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 216nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 227nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 228nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 238nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 253nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 259nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 286nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 298nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 378nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 648nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 665nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 678nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 686nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 776nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 780nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 824nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.03E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.13E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.14E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.18E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.29E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.57E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.68E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 1.72E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.23E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.43E+3nMAssay Description:Antagonist activity at human Gq-coupled PRLHR expressed in CHOK1 cells assessed as inhibition in prolactin releasing peptide (1 to 31)-induced beta-a...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.44E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 2.79E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 3.35E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 3.60E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 3.71E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 3.90E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 4.49E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 4.89E+3nMAssay Description:Antagonist activity at human PRLHR expressed in CHO-K1 cells by PathHunter beta-arrestin assayMore data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataIC50: 5.79E+3nMpH: 7.4 T: 2°CAssay Description:HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...More data for this Ligand-Target Pair
